Dr. Lal Path Labs Ltd. (LALPATHLAB) Share Analysis
NSE · Healthcare · Hospital & Healthcare Services
Dr. Lal Path Labs Ltd. (NSE: LALPATHLAB) is an Indian listed company in the Hospital & Healthcare Services sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100. As of 21 Sep 2026, the share price was ₹1,897.00, market capitalisation ₹31,839 Cr, P/E 56.6, ROE 22.3%.
Get the AI verdict on LALPATHLAB: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
LALPATHLAB price and valuation
- Share price
- ₹1,897.00
- Market cap
- ₹31,839 Cr
- P/E ratio
- 56.6
- P/B ratio
- 12.65
- EPS
- ₹32.34
- Book value per share
- ₹150.00
- Dividend yield
- 0.74%
LALPATHLAB profitability and growth
- ROE
- 22.3%
- ROCE
- 28%
- Debt to equity
- 0.08
- Revenue growth (3 yr)
- 11%
- Revenue growth (5 yr)
- 12%
- Profit growth (3 yr)
- 30%
- Profit growth (5 yr)
- 12%
LALPATHLAB 52-week range
- 52-week high
- ₹2,038.60
- 52-week low
- ₹1,272.60
- Face value
- ₹10.00
LALPATHLAB shareholding pattern
- Promoters
- 53.19%
- FIIs
- 17.35%
- DIIs
- 21.59%
- Public
- 7.48%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.
